Section of Clinical Sciences - News and Features

SCS in News

Prior (pre-2019)

Interleukin-1 Blockade Can Prevent Gout Attacks

Solomon DH

Nov 19, 2018


SCS's Dr. Liao featured in Dell Technologies Video

SCS Investigator Dr. Kat Liao was featured in a video by Dell Technologies, discussing her passion for clinical research and her innovative work using analytical tools to treat rheumatic disease patients. Check out the video below.


SCS Faculty Dr. Sparks Speaks at March Digital Research Forum

Join Dr. Sparks this Tuesday 3/14 at 8am as he discusses the role of bioinformatics in identifying pneumonia in the electronic medical record.

Location: Building for Transformative Medicine, 3rd Floor Conference Room

Register here.


Congratulations to SCS Project Manager Alyssa Wohlfahrt on her well-deserved Brigham and Women’s Partners in Excellence award in the category of operational efficiency!

View the full list of award recipients here.


Dr. Tedeschi Featured in Rheumatology News

Today we are highlighting two articles, one in Rheumatology News and the other on Med Page Today, featuring Dr. Sara Tedeschi’s recent publication on Rheumatoid Arthritis (RA) symptoms and diet. In a survey of 217 participants in the Brigham RA Sequential Study, 24% of patients reported that certain foods affect their RA symptoms. Foods that improved symptoms included blueberries (11.1%) and fish (10.9%); foods associated with worsened symptoms were desserts (12.7%) and soda with sugar (12.4%). These results point to a potential link between inflammation and sugar consumption that may call for closer investigation.

Find the article in Rheumatology News here and the Med Page Today article here.

Read the full paper here.


SCS Investigator Video Series- Dr. Lee

Over the next year, meet the BWH Section of Clinical Sciences faculty by video and learn first-hand about their research and recent publications. This month we are featuring Dr. Yvonne Lee, Assistant Professor of Medicine, who describes her research focused on the inflammatory and non-inflammatory components of pain in the rheumatic diseases. She also discusses her recent publication https://goo.gl/GX0wXX

This study used innovative statistical modeling techniques to show that bodily pain increases during the time surrounding menopause and then decreases after menopause. It is important because it points to potential differences in the underlying mechanisms of pain in women as they undergo the menopause transition.


SCS Faculty Dr. Candace Feldman, M.D.,M.P.H. has K23 grant approved for research in Lupus

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) has approved a K23 grant application by SCS faculty Dr. Candace Feldman, M.D.,M.P.H. titled "Avoidable Acute Care Use among Patients with Lupus". Dr. Feldman hopes to understand predictors, outcomes and costs associated with potentially avoidable acute care use among vulnerable patients with lupus. Congratulations to Dr. Feldman for all her hard work and dedication!


An Update on the Matthew H. Liang Distinguished Chair in Arthritis and Population Health

Message from Daniel Solomon, MD, MPH from Brigham and Women's Hospital on Vimeo.

In a new video message from Daniel Solomon, MD, MPH, the inaugural incumbent of the Matthew H. Liang Distinguished Chair in Arthritis and Population Health, Dr. Solomon explains how resources provided by the Liang Chair have allowed him to advance key efforts in education, research, and training in the Division of Rheumatology and the Section of Clinical Sciences at Brigham and Women’s Hospital. These efforts—made possible through the generosity of our patients, colleagues, and friends—are critical to fostering the careers of our bright young investigators, furthering knowledge in the field, and translating the discoveries we make into life-changing advances in patient care.


The SQIL Model for Quality Improvement in Healthcare

Today we are highlighting an article by Dr. Sonali Desai about her Harvard Medical School course that aims to improve healthcare quality. The program, called Safety, Quality, Informatics, and Leadership (SQIL) provides continuing education to professionals across disciplines and emphasizes active learning. Through collaboration, it aims to foster a culture of constant improvement to drive healthcare forward.

Read the article here.


PRECISION Trial Results: Celecoxib just as safe as naproxen or ibuprofen in OA and RA

During this year’s American College of Rheumatology annual meeting, Dr. Daniel Solomon presented on the safety of celecoxib relative to other NSAIDs. The PRECISON (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen) trial enrolled about 24,000 patients with osteoarthritis or rheumatoid arthritis. The patients were randomized to celecoxib, naproxen, or ibuprofen and were followed for about 24 months. The study found celecoxib was just as safe as naproxen or ibuprofen in patients with osteoarthritis and rheumatoid arthritis. Patients taking celecoxib were found to have lower incidence of cardiovascular events as well as lower risk of both gastrointestinal and renal adverse events. These findings were released November 13th in the New England Journal of Medicine.

Read the article here.

Watch Dr. Solomon’s interview here.


To the Editor: Individuals with Type 2 Diabetes Mellitus

Dr. Lindsey MacFarlane's Letter to the Editor, published in Medicine, responds to the Wijnands et al article, "Individuals with Type 2 Diabetes Mellitus Are at an Increased Risk of Gout But This Is Not Due to Diabetes: A Population-Based Cohort Study".

You can read the full letter on the Medicine Correspondence Blog.


Drs. Solomon and Kim recieve BWH mentoring awards

Drs. Solomon and Kim were honored at the Department of Medicine Grand Rounds on January 23 for their service as research mentors. Dr. Solomon is a recipient of the prestigious Kenneth L. Baughman Faculty Mentoring Award. His mentee, Dr. Seoyoung Kim, now with mentees of her own, is a recipient of the Early Career Mentoring Award.

Please join us in congratulating them both.


Dr. Solomon Honored as Incumbent Matt Liang Distinguished Chair

On Monday, December 10, 2014 the BWH community celebrated the establishment of the Matthew H. Liang Distinguished Chair in Arthritis and Population Health, honoring Dr. Solomon, as the first incumbent. The Matthew H. Liang Chair was created through the generous support of Ms. Ann Garthwaite and Dr. Liang’s patients to promote investigative research in the epidemiology of rheumatic diseases. During the ceremony, BWH President Dr. Betsy Nabel and Rheumatology Division Chief Dr. Michael Brenner spoke about the leadership of Drs. Solomon and Liang in the development and success of the Section of Clinical Sciences. Dr. Solomon’s mentors and colleagues, Drs. Matt Liang and Jeff Katz emphasized Dr. Solomon’s intellectual curiosity and dedication to patient care as a driving force to his research, and Dr. Solomon’s mentee, Dr. Yvonne Lee, highlighted his strong support of the new generation of population scientists.


Interview with Dr. Sparks

Dr. Jeffrey Sparks comments on his study highlighting comparing causes of mortality in Rheumatoid Arthritis compared to the general population. This study conducted in the Nurses' Health Study, suggests pulmonary disease is a major and under recognized cause of death in RA.

The following link provides a video of the interview: Rheumatology News